WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 72.70
-1.30 (-1.76%)
Sep 17, 2025, 1:30 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.31 billion as of September 17, 2025. Its market cap has increased by 10.44% in one year.
Market Cap
3.31B
Enterprise Value
3.83B
Revenue
1.02B
Ranking
n/a
PE Ratio
17.90
Stock Price
72.70
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.31B, a decrease of -3.61%. That is a compound annual growth rate of -2.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 3.31B | 1.95% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 322.61B |
| PharmaEssentia | 183.07B |
| Bora Pharmaceuticals Co., LTD. | 87.37B |
| Lumosa Therapeutics | 49.78B |
| Lotus Pharmaceutical | 48.91B |
| Oneness Biotech | 33.67B |
| Polaris Group | 29.47B |
| Center Laboratories | 27.25B |